Olah, Marta https://orcid.org/0000-0003-4945-855X
Menon, Vilas https://orcid.org/0000-0002-4096-8601
Habib, Naomi https://orcid.org/0000-0002-6049-2487
Taga, Mariko F.
Ma, Yiyi https://orcid.org/0000-0002-3609-8877
Yung, Christina J.
Cimpean, Maria https://orcid.org/0000-0003-3735-2643
Khairallah, Anthony
Coronas-Samano, Guillermo
Sankowski, Roman https://orcid.org/0000-0001-9215-8021
Grün, Dominic
Kroshilina, Alexandra A.
Dionne, Danielle https://orcid.org/0000-0002-8338-4323
Sarkis, Rani A. https://orcid.org/0000-0001-8291-7864
Cosgrove, Garth R.
Helgager, Jeffrey
Golden, Jeffrey A.
Pennell, Page B.
Prinz, Marco https://orcid.org/0000-0002-0349-1955
Vonsattel, Jean Paul G.
Teich, Andrew F. https://orcid.org/0000-0002-1916-8490
Schneider, Julie A.
Bennett, David A.
Regev, Aviv https://orcid.org/0000-0003-3293-3158
Elyaman, Wassim
Bradshaw, Elizabeth M.
De Jager, Philip L. https://orcid.org/0000-0002-8057-2505
Funding for this research was provided by:
Alzheimer’s Association (AARF-17-505638)
U.S. Department of Health & Human Services | NIH | Center for Scientific Review (AG046152, AG036836, AG048015, AG057473, NS089674)
U.S. Department of Health & Human Services | NIH | Center for Scientific Review
U.S. Department of Health & Human Services | NIH | Center for Scientific Review
U.S. Department of Health & Human Services | NIH | Center for Scientific Review
U.S. Department of Health & Human Services | NIH | Center for Scientific Review
Article History
Received: 31 August 2019
Accepted: 26 October 2020
First Online: 30 November 2020
Competing interests
: A.R. is a co-founder and equity holder of Celsius Therapeutics, an equity holder in Immunitas, and was an SAB member of ThermoFisher Scientific, Syros Pharmaceuticals, Neogene Therapeutics and Asimov. From August 1, 2020, A.R. is now an employee of Genentech. All other authors declare no competing interests.